Skip to content

J-C Grace Pharmacy

Active
Private limited company (pre-2019)founded 2017active for 9 yearsBischoffsheimlaan 39, 1000 Brussel, Belgium429 active companies are registered at this addressKBO/BCE: BE 0670.963.549
Summary

The computed 12-month bankruptcy probability of J-C Grace Pharmacy is 1.6% (moderate). The 2025 annual accounts show equity of €251,502 and a net result of €28,187. Equity is growing by about 32% per year across the filed financial years. Its solvency ranks better than 77% of 22,536 sector peers (NACE 47, financial year 2025). The company has been active since 2017 and the Belgian Official Gazette contains no insolvency or warning signals.

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
€386,831total assets 2025
Equity
€251,502
Profit
€28,187
Financial health
64 Healthy Checked score 2025
Bankruptcy probabilitywithin 12 months
1.6%
Structure
2025 accounts 18 days early1 of 2 deeds summarised
Why 64raises riskLiquidity: current ratio 2.861 of the last 3 lateSector: Retail trade (NACE 47)lowers riskEquity €251,502 (65.0% of total assets)Show the evidence

Checked score

Score 2025
64 / 100
Healthy
Probability in this band: 0.55% to 1.5%
Financially better than 64% of its sector peers (NACE 47, micro)
Financial strength · tick = 2024
Strong
Solvency 90+12
equity 65.0% of total assets
Liquidity 69+40
short-term debt 35.0%
Profitability 56-9
return on assets 7.3%
Bankruptcy probability, 12 months
1.6% Moderate
0%0.5%1.5%4%10%≥ 25%

About 2 in 100 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,231 companies, NACE 47, micro)
Last 24 months 11-2024: 13.3% 12-2024: 14.3%▲ +1.0 percentage point vs 11-2024 01-2025: 16.6%▲ +2.3 percentage points vs 12-2024 02-2025: 16.3%▼ -0.3 percentage points vs 01-2025 03-2025: 16.8%▲ +0.5 percentage points vs 02-2025highest value 04-2025: 15.6%▼ -1.2 percentage points vs 03-2025 05-2025: 9.2%▼ -6.4 percentage points vs 04-2025 06-2025: 8.9%▼ -0.3 percentage points vs 05-2025 07-2025: 8.1%▼ -0.8 percentage points vs 06-2025 08-2025: 9.1%▲ +1.0 percentage point vs 07-2025 09-2025: 1.9%▼ -7.2 percentage points vs 08-2025 10-2025: 1.9%● unchanged vs 09-2025 11-2025: 1.9%● unchanged vs 10-2025 12-2025: 1.9%● unchanged vs 11-2025 01-2026: 1.9%● unchanged vs 12-2025 02-2026: 1.9%● unchanged vs 01-2026 03-2026: 1.8%▼ -0.1 percentage points vs 02-2026 04-2026: 1.1%▼ -0.7 percentage points vs 03-2026lowest value 05-2026: 1.2%▲ +0.1 percentage points vs 04-2026 06-2026: 1.2%● unchanged vs 05-2026 07-2026: 1.1%▼ -0.1 percentage points vs 06-2026 08-2026: 1.6%▲ +0.5 percentage points vs 07-2026 09-2026: 1.6%● unchanged vs 08-2026 10-2026: 1.6%● unchanged vs 09-2026
Credit of up to €16,000 on 30-day terms is acceptable
Liquidity ample (current ratio 2.86, compared with 2.29 in 2024, above the usual 1.5; short-term debt: 35% of total assets), and 35% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 77% on solvency, 75% on liquidity, 40% on profitability and 64% on growth.

The bankruptcy probability was computed on 24-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
raises risk · Liquidity: current ratio 2.86
NBB · annual accounts
raises risk · 1 of the last 3 late
NBB · filings
raises risk · Sector: Retail trade (NACE 47)
KBO
lowers risk · Equity €251,502 (65.0% of total assets)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 13-07-2026, 18 days ahead of the deadline.
NBB · 9 filings
Deviation from the deadline
2025
18 days early
2024
28 days late
2023
272 days late
2022
109 days late
2021
32 days late
2020
51 days late
2019
21 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 65 days after the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 1 September (4 of the last 5 filed years within 77 days of that day).
Companies Code · seven months
Where today falls in the filing period
25-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Annual accounts filedfinancial year 2024 · micro…
  3. Annual accounts filedfinancial year 2023 · micro…

Key points

  • Positive: Among the best 12% on equitysector median €41,219 · 22,577 companies €251,502 View
  • Positive: 6 profitable years in a rowprofit 2025: €28,187 6 years View
  • Total assets 20256 financial years filed €386,831 View

By topic

Financials

Financial year
2025
Total assets
€386,831
Profit
€28,187
Solvency
65.0%
Total assets▼ 7.6%
Net result
20182025
Go to Financials

Timeline

Events
15
Since
2018
Next accounts
by 31-07-2027
  1. 31-12-2024Equity above €200,000
  2. 19-03-2024Registered office
  3. 31-12-2023Equity above €150,000
Go to Timeline

Company details

Sites
1
Legal form
Private limited company (pre-2019)
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
10-02-2017
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Key facts about J-C Grace Pharmacy

What is the company number of J-C Grace Pharmacy?
0670.963.549. In Belgium the VAT number is the company number with BE in front: BE 0670.963.549.
Where is J-C Grace Pharmacy based?
The registered office is at Bischoffsheimlaan 39, 1000 Brussel.Company details
What does J-C Grace Pharmacy do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of J-C Grace Pharmacy?
Private limited company (pre-2019) (BVBA).
When was J-C Grace Pharmacy founded?
On 10-02-2017.
Is J-C Grace Pharmacy still active?
Yes, J-C Grace Pharmacy is an active enterprise in the KBO register.
What is the turnover of J-C Grace Pharmacy?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
Is J-C Grace Pharmacy profitable?
In financial year 2025, J-C Grace Pharmacy made a profit of €28,187.
Where can I find the annual accounts of J-C Grace Pharmacy?
J-C Grace Pharmacy filed 9 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of J-C Grace Pharmacy due?
By 31-07-2027, for financial year 2026.Timeline

Companies related to J-C Grace Pharmacy

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.